Medical devices on clinic table, echoing Abbott's diagnostics and devices ahead of healthcare earnings. Key Points An acceleration from last quarter's 4% year-over-year growth in nutrition segment sales could help boost Abbott Laboratories' revenue performance. Intuitive Surgical's preliminary fourth-quarter earnings results led to a modest dip in share price, perhaps due to middling forecasted da Vinci procedure growth for 2026. Still, overall adoption and revenue growth rates remain high, and the tem ...